The main focus of Dr Antonia Cronin's academic work is the ethical and legal analysis on matters raised by scientific research and clinical practice, in particular the regulation of organ donation and transplantation and the translation of its related research into clinical practice. Her work draws on interdisciplinary insights gained from science, medicine, social science, philosophical bioethics, public policy and the law.
She has been appointed expert reviewer for the European Council, the National Institute for Health Research (NIHR) and the Wellcome Trust. She regularly undertakes peer review for numerous academic journals including Transplantation, Transplant International, The Lancet, Medical Law Review, Journal of Medical Ethics, Bioethics, Nature Reviews Nephrology and The American Journal of Transplantation.
She is currently ethics advisor to several collaborative translational research consortia in receipt of over €15 million funding by the European Commission Horizon 2020 scheme. These include:
- 2020-2025 VANGUARD New Generation Cell Therapy: Bioartificial Pancreas to Cure Type 1 Diabetes
- 2019-2024 RESHAPE Consortium: Reshaping undesired Inflammation in challenged Tissue Homeostasis by Next-Generation regulatory T cell (Treg) Approaches - from Advanced Technology Developments to First-in-Human Trials.
- 2016-2020 ENCKEP: European Network for Collaboration on Kidney Exchange Programmes.
- 2013-2019 BioDRIm Consortium: BIOmarker-DRiven personalised Immunosuppression in the implementation of biomarker driven strategies for personalising immunosuppression.
She sits on the advisory board of the MRC funded project ‘About Face’, the first interdisciplinary study of the affective and cultural history of face transplants, and the implications for innovative surgical practice.